Pharma IQ Members

Supply Chain & Security
33 results
of 3
Contributor: Pharma IQ
Posted: Mon, 12/12/2016
cyber security, cyber attack, cyber. medical devices, software for medical devices, healthcare, patients, hacker, hack, malicious software, protection, cyber protection
The world of healthcare has greatly benefitted from enhanced connectivity as a by-product of the digital age. However, this benefit has contributed to exposing medical devices and their softwares to cyber attacks. Malicious digital interferences can be significantly detrimental to patient safety.Ahead of the 2017 Software for Medical Devices conference, Pharma IQ brings you this whitepaper looking at what you need to know in regards to software cyber security to medical devices. Full Content »
Contributor: Pharma Logistics IQ
Posted: Mon, 10/10/2016
Seri
The war against counterfeit pharmaceuticals in the supply chain is well underway, with more than 40 markets – those of which including the EU, US, South Korea, Brazil and China, deploying pharmaceutical track and trace laws. According to industry specialist Tracelink, by the end of 2018 more than 75% of the globe’s prescription medications are expected to be protected by legislation. Full Content »
Contributor: Pharma IQ
Posted: Tue, 09/20/2016
Serialisation, Serialization, CMOS, contract manufacturing organisation, small and medium enterprise, pharma, biotech, pharmaceutical
Pharma IQ spoke to Mark Davison, Chief Executive Officer Blue Sphere Health Ltd to gain insight on his experience working with SME pharma & biotechs for serialisation. Also we spoke to Vetter pharma – a responsible CMO for their insight on how peer CMOs can scale the summit that is serialisation. Full Content »
Contributor: Andrew Love
Posted: Tue, 09/06/2016
Andrew Love
This next series explains, in a series of learning points, some of the key things that we wish we had known before embarking on our early projects. Full Content »
Contributor: Pharma IQ
Posted: Thu, 08/11/2016
cover
Industry stakeholders have insisted that it could be a costly mistake to view serialisation as a project which only concerns engineering matters. As serialisation data is unique to the pack it requires not only the deployment of new treatment but also expanded staff investment and stakeholder engagement. Therefore, “To characterize it as an engineering issue is therefore to grossly underestimate its consequences, which touch virtually every business function in pharmaceutical manufacturing.” Full Content »
Contributor: Pharma IQ
Posted: Tue, 07/26/2016
Pharma IQ
Much growth in the sector is being driven by expansion into developing markets, thus increasing demand for people with international experience. Taking the supply chain as an example, although track-and-trace initiatives should simplify and facilitate logistics in the long-term, in the short term there may be increasing competition for those with specialist knowledge of developing markets. Full Content »
Contributor: Pharma IQ
Posted: Tue, 07/19/2016
seri
As the serialisation industry prepares for various approaching deadlines all over the globe, Pharma IQ has created a printable map to assist with your worldwide track and trace compliance strategies. Full Content »
Contributor: Chanice Henry
Posted: Mon, 05/23/2016
Patient Compliance
The packaging, labelling and artwork division of the pharma market faces pressure from a range of directions. Varying country requirements, refreshed regulations, controlling the demanding overheads and arguably the one of the most costly pressures is the combat against pharmaceutical inappropriate use by patients. Pharmaceuticals taken incorrectly are a public safety concern, leading to a significant level of fatalities each year. Full Content »
Posted: Fri, 05/20/2016
Vjet WP2
The Whitepaper outlines the requirements for compliance with the DSCSA, and discusses the challenges facing the pharmaceutical industry. Various strategies will be explored as well as how to take maximum advantage of the supply chain benefits that can be achieved with the right planning and implementation. T Full Content »
Contributor: Andrew Love
Posted: Mon, 05/16/2016
Andrew Love
In the last article I looked at the starting point of developing your organisation’s strategy, the legislation and its impact. In this article I discuss defining your solution, what to look for when picking your implementation partners and the key aspects to consider when resourcing the project team. Full Content »
Contributor: Pharma IQ
Posted: Fri, 05/06/2016
P&L report image
According to recent research, the global pharmaceutical packaging market is forecasted to reach more than US$80 billion in revenue by 2020.

This expanding market is advancing towards optimization in regards to effectiveness. However, as noted in recent research, this wasn’t always the case: “Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago. But of late, pharmaceutical packaging has quickly become an essential part of the drug delivery system..” (1) Full Content »
33 results
of 3
Contributor: Pharma IQ
Posted: Mon, 12/12/2016
Pharma IQ
The world of healthcare has greatly benefitted from enhanced connectivity as a by-product of the digital age. However, this benefit has contributed to exposing medical devices and their softwares to cyber attacks. Malicious digital interferences can be significantly detrimental to patient safety.Ahead of the 2017 Software for Medical Devices conference, Pharma IQ brings you this whitepaper looking at what you need to know in regards to software cyber security to medical devices. Full Sector Report »